Evidence map›Paper›PMID 17726056›Full record

ArticleNucleic acids research2007

The checkpoint Saccharomyces cerevisiae Rad9 protein contains a tandem tudor domain that recognizes DNA.

Nathalie Lancelot, Gaëlle Charier, Joël Couprie, Isabelle Duband-Goulet, Béatrice Alpha-Bazin, Eric Quémeneur, Emilie Ma, Marie-Claude Marsolier-Kergoat, Virginie Ropars, Jean-Baptiste Charbonnier and 5 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 30 citations in OpenAlex.

  1. TPI and GAPDH Interact with Rad9, Linking Glycolytic Enzymes to Cancer.International journal of molecular sciences · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Nathalie LancelotInstitut de Biologie et Technologies de Saclay, CEA Saclay, 91191 Gif-sur-Yvette, France.
Gaëlle Charier
Joël Couprie
Isabelle Duband-Goulet
Béatrice Alpha-Bazin
Eric Quémeneur
Emilie Ma
Marie-Claude Marsolier-Kergoat
Virginie Ropars
Jean-Baptiste Charbonnier
Simona Miron
Constantin T Craescu
Isabelle Callebaut
Bernard Gilquin
Sophie Zinn-Justin
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

DNA damage checkpoints are signal transduction pathways that are activated after genotoxic insults to protect genomic integrity. At the site of DNA damage, 'mediator' proteins are in charge of recruiting 'signal transducers' to molecules 'sensing' the damage. Budding yeast Rad9, fission yeast Crb2 and metazoan 53BP1 are presented as mediators involved in the activation of checkpoint kinases. Here we show that, despite low sequence conservation, Rad9 exhibits a tandem tudor domain structurally close to those found in human/mouse 53BP1 and fission yeast Crb2. Moreover, this region is important for the resistance of Saccharomyces cerevisiae to different genotoxic stresses. It does not mediate direct binding to a histone H3 peptide dimethylated on K79, nor to a histone H4 peptide dimethylated on lysine 20, as was demonstrated for 53BP1. However, the tandem tudor region of Rad9 directly interacts with single-stranded DNA and double-stranded DNAs of various lengths and sequences through a positively charged region absent from 53BP1 and Crb2 but present in several yeast Rad9 homologs. Our results argue that the tandem tudor domains of Rad9, Crb2 and 53BP1 mediate chromatin binding next to double-strand breaks. However, their modes of chromatin recognition are different, suggesting that the corresponding interactions are differently regulated.

Indexed as

DNA Breaks, Double-StrandedAmino Acid SequenceAnimalsCell Cycle ProteinsCheckpoint Kinase 2DNADNA-Binding ProteinsG1 PhaseHistonesHumansIntracellular Signaling Peptides and ProteinsMiceMolecular Sequence DataNuclear ProteinsProtein Serine-Threonine KinasesProtein Structure, TertiaryCell Cycle ProteinsCheckpoint Kinase 2Crb2 protein, S pombeDNADNA-Binding ProteinsHistonesIntracellular Signaling Peptides and ProteinsNuclear ProteinsProtein Serine-Threonine KinasesRAD53 protein, S cerevisiaerad9 proteinSaccharomyces cerevisiae ProteinsSchizosaccharomyces pombe ProteinsTP53BP1 protein, humanTumor Suppressor p53-Binding Protein 1

Identifiers

PMID17726056
PMCPMC2034471
OpenAlexW2012928586

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.